<DOC>
	<DOCNO>NCT01448135</DOCNO>
	<brief_summary>The purpose pilot study ass efficacy , safety tolerance profile enteral feed product VITAL AF ( semi-elemental , high protein , high omega-3 fish oil ) compare Osmolite 1.2 , standard feed product critically ill and/or post surgical patient intensive care unit ( ICU ) . If enough patient recruit , inference impact outcome may also draw .</brief_summary>
	<brief_title>Tolerance Efficacy Predigested , High Protein , High Omega 3 Fat Enteral Feeding Formula Versus Standard Formula In Multiple Intensive Care Unit Settings</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<criteria>Subject require enteral tube feed sole source nourishment Subject , subject 's legally acceptable representative ( LAR ) , provide voluntarily inform consent form , deemed appropriate approve Columbia University Medical Center Institutional Review Board Subject â‰¥ 18 year age Subject male nonpregnant female least six week postpartum nonlactating female childbearing potential require confirm nonpregnancy status pregnancy test screen Subject initial APACHE II score less equal 24 Subject require parenteral nutrition Subject acutely impact constipated Subject intestinal obstruction Subject hemodynamically unstable enteral feeding Subject allergy intolerance ingredient study product documentation verbal report subject subject 's LAR Subject participate nonAbbott approve concomitant trial Subject gastrointestinal disease , include acute pancreatitis , active gastrointestinal bleeding , acute inflammatory bowel disease , undergone intestinal surgery within past month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>